Key result
Rapid genetic analysis of ABBC8 and KCNJ11 genes identified mutations in 2 of 4 patients with congenital hyperinsulinism, but was non-informative in the remaining 2 patients.
Why the study?
Does rapid genetic analysis of ABBC8 and KCNJ11 genes help differentiate focal from diffuse disease in patients with severe congenital hyperinsulinism?
Case Report (n=4)
Does rapid genetic analysis of ABBC8 and KCNJ11 genes help differentiate focal from diffuse disease in patients with severe congenital hyperinsulinism?
Rapid genetic analysis of ABBC8 and KCNJ11 genes has limited standalone utility in the preoperative assessment of congenital hyperinsulinism unless specific maternal or homozygous/compound heterozygous mutations are found.
Rapid ABBC8/KCNJ11 analysis offers limited preoperative utility in congenital hyperinsulinism; leaves open need for larger validation studies.
BACKGROUND: In severe, medically unresponsive congenital hyperinsulinism (CHI), the histological differentiation of focal versus diffuse disease is vital, since the surgical management is completely different. Genetic analysis may help in the differential diagnosis, as focal CHI is associated with a paternal germline ABCC8 or KCNJ11 mutation and a focal loss of maternal chromosome 11p15, whereas a maternal mutation, or homozygous/compound heterozygous ABCC8 and KCNJ11 mutations predict diffuse-type disease. However, genotyping usually takes too long to be helpful in the absence of a founder mutation. METHODS: In 4 patients, a rapid genetic analysis of the ABBC8 and KCNJ11 genes was performed within 2 weeks on request prior to the decision of pancreatic surgery. RESULTS: Two patients had no mutations, rendering the genetic analysis non-informative. Peroperative multiple biopsies showed diffuse disease. One patient had a paternal KCNJ11 mutation and focal disease confirmed by positron emission tomography scan and biopsies. One patient had a de novo heterozygous ABBC8 mutation and unexplained diffuse disease confirmed by positron emission tomography scan and biopsies. CONCLUSION: A rapid analysis of the entire ABBC8 and KCNJ11 genes should not stand alone in the preoperative assessment of patients with CHI, except for the case of maternal, or homozygous/compound heterozygous disease-causing mutations.
No takes yet. Share an insight, caveat, or question.
Christesen et al. (2006) conducted a case report in Congenital hyperinsulinism (n=4). Rapid genetic analysis of ABBC8 and KCNJ11 genes was evaluated on Diagnostic utility for differentiating focal versus diffuse disease. Rapid genetic analysis of ABBC8 and KCNJ11 genes identified mutations in 2 of 4 patients with congenital hyperinsulinism, but was non-informative in the remaining 2 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: